annual FCF:
-$571.79M-$207.12M(-56.80%)Summary
- As of today (July 3, 2025), PCVX annual free cash flow is -$571.79 million, with the most recent change of -$207.12 million (-56.80%) on December 31, 2024.
- During the last 3 years, PCVX annual FCF has fallen by -$443.84 million (-346.89%).
- PCVX annual FCF is now -1673.53% below its all-time high of -$32.24 million, reached on December 31, 2018.
Performance
PCVX Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$193.03M-$51.60M(-36.48%)Summary
- As of today (July 3, 2025), PCVX quarterly free cash flow is -$193.03 million, with the most recent change of -$51.60 million (-36.48%) on March 31, 2025.
- Over the past year, PCVX quarterly FCF has dropped by -$21.83 million (-12.75%).
- PCVX quarterly FCF is now -1991.96% below its all-time high of -$9.23 million, reached on June 30, 2020.
Performance
PCVX quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$593.62M-$21.83M(-3.82%)Summary
- As of today (July 3, 2025), PCVX TTM free cash flow is -$593.62 million, with the most recent change of -$21.83 million (-3.82%) on March 31, 2025.
- Over the past year, PCVX TTM FCF has dropped by -$111.05 million (-23.01%).
- PCVX TTM FCF is now -5967.20% below its all-time high of -$9.78 million, reached on March 31, 2019.
Performance
PCVX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
PCVX Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -56.8% | -12.8% | -23.0% |
| 3 y3 years | -346.9% | -530.4% | -311.9% |
| 5 y5 years | -1082.8% | -1280.5% | -1134.5% |
PCVX Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -346.9% | at low | -390.0% | at low | -287.2% | +3.7% |
| 5 y | 5-year | -1096.6% | at low | -1992.0% | at low | -1142.3% | +3.7% |
| alltime | all time | -1673.5% | at low | -1992.0% | at low | -5967.2% | +3.7% |
PCVX Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$193.03M(+36.5%) | -$593.62M(+3.8%) |
| Dec 2024 | -$571.79M(+56.8%) | -$141.43M(+43.2%) | -$571.79M(-7.2%) |
| Sep 2024 | - | -$98.79M(-38.4%) | -$616.24M(+5.8%) |
| Jun 2024 | - | -$160.37M(-6.3%) | -$582.34M(+20.7%) |
| Mar 2024 | - | -$171.20M(-7.9%) | -$482.56M(+32.3%) |
| Dec 2023 | -$364.67M(+106.7%) | -$185.88M(+186.5%) | -$364.67M(+48.8%) |
| Sep 2023 | - | -$64.89M(+7.1%) | -$245.15M(+11.6%) |
| Jun 2023 | - | -$60.60M(+13.7%) | -$219.65M(+10.3%) |
| Mar 2023 | - | -$53.30M(-19.7%) | -$199.12M(+12.9%) |
| Dec 2022 | -$176.44M(+37.9%) | -$66.36M(+68.5%) | -$176.44M(+8.5%) |
| Sep 2022 | - | -$39.39M(-1.7%) | -$162.55M(+6.0%) |
| Jun 2022 | - | -$40.06M(+30.8%) | -$153.29M(+6.4%) |
| Mar 2022 | - | -$30.62M(-41.6%) | -$144.12M(+12.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$127.95M(+167.8%) | -$52.48M(+74.1%) | -$127.95M(+47.1%) |
| Sep 2021 | - | -$30.13M(-2.4%) | -$86.96M(+24.4%) |
| Jun 2021 | - | -$30.89M(+113.7%) | -$69.91M(+44.9%) |
| Mar 2021 | - | -$14.45M(+25.8%) | -$48.25M(+1.0%) |
| Dec 2020 | -$47.78M(-1.2%) | -$11.49M(-12.2%) | -$47.78M(-7.5%) |
| Sep 2020 | - | -$13.08M(+41.8%) | -$51.65M(+7.4%) |
| Jun 2020 | - | -$9.23M(-34.0%) | -$48.09M(-8.5%) |
| Mar 2020 | - | -$13.98M(-9.0%) | -$52.54M(+8.7%) |
| Dec 2019 | -$48.34M(+49.9%) | -$15.36M(+61.4%) | -$48.34M(+46.6%) |
| Sep 2019 | - | -$9.52M(-30.4%) | -$32.98M(+40.6%) |
| Jun 2019 | - | -$13.68M(+39.8%) | -$23.46M(+139.8%) |
| Mar 2019 | - | -$9.78M | -$9.78M |
| Dec 2018 | -$32.24M | - | - |
FAQ
- What is Vaxcyte annual free cash flow?
- What is the all time high annual FCF for Vaxcyte?
- What is Vaxcyte annual FCF year-on-year change?
- What is Vaxcyte quarterly free cash flow?
- What is the all time high quarterly FCF for Vaxcyte?
- What is Vaxcyte quarterly FCF year-on-year change?
- What is Vaxcyte TTM free cash flow?
- What is the all time high TTM FCF for Vaxcyte?
- What is Vaxcyte TTM FCF year-on-year change?
What is Vaxcyte annual free cash flow?
The current annual FCF of PCVX is -$571.79M
What is the all time high annual FCF for Vaxcyte?
Vaxcyte all-time high annual free cash flow is -$32.24M
What is Vaxcyte annual FCF year-on-year change?
Over the past year, PCVX annual free cash flow has changed by -$207.12M (-56.80%)
What is Vaxcyte quarterly free cash flow?
The current quarterly FCF of PCVX is -$193.03M
What is the all time high quarterly FCF for Vaxcyte?
Vaxcyte all-time high quarterly free cash flow is -$9.23M
What is Vaxcyte quarterly FCF year-on-year change?
Over the past year, PCVX quarterly free cash flow has changed by -$21.83M (-12.75%)
What is Vaxcyte TTM free cash flow?
The current TTM FCF of PCVX is -$593.62M
What is the all time high TTM FCF for Vaxcyte?
Vaxcyte all-time high TTM free cash flow is -$9.78M
What is Vaxcyte TTM FCF year-on-year change?
Over the past year, PCVX TTM free cash flow has changed by -$111.05M (-23.01%)